185 related articles for article (PubMed ID: 19760557)
41. Biology of Hodgkin's lymphoma.
Küppers R; Schwering I; Bräuninger A; Rajewsky K; Hansmann ML
Ann Oncol; 2002; 13 Suppl 1():11-8. PubMed ID: 12078890
[TBL] [Abstract][Full Text] [Related]
42. Advances in biology, diagnostics, and treatment of Hodgkin's disease.
Küppers R; Yahalom J; Josting A
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):66-76. PubMed ID: 16399588
[TBL] [Abstract][Full Text] [Related]
43. Molecular biology of Hodgkin lymphoma.
Weniger MA; Küppers R
Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
[TBL] [Abstract][Full Text] [Related]
44. NF-κB deregulation in Hodgkin lymphoma.
Weniger MA; Küppers R
Semin Cancer Biol; 2016 Aug; 39():32-9. PubMed ID: 27221964
[TBL] [Abstract][Full Text] [Related]
45. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
[TBL] [Abstract][Full Text] [Related]
46. Ultrafast Papanicolaou stain and cell-transfer technique enhance cytologic diagnosis of Hodgkin lymphoma.
Zu Y; Gangi MD; Yang GC
Diagn Cytopathol; 2002 Nov; 27(5):308-11. PubMed ID: 12411999
[TBL] [Abstract][Full Text] [Related]
47. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma.
Claesson HE; Griffiths WJ; Brunnström A; Schain F; Andersson E; Feltenmark S; Johnson HA; Porwit A; Sjöberg J; Björkholm M
FEBS J; 2008 Aug; 275(16):4222-34. PubMed ID: 18647347
[TBL] [Abstract][Full Text] [Related]
48. Molecular pathogenesis of Hodgkin lymphoma.
Nishikori M; Uchiyama T
Int J Hematol; 2006 Jun; 83(5):398-403. PubMed ID: 16787869
[TBL] [Abstract][Full Text] [Related]
49. Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
von Hoff L; Kärgel E; Franke V; McShane E; Schulz-Beiss KW; Patone G; Schleussner N; Kolesnichenko M; Hübner N; Daumke O; Selbach M; Akalin A; Mathas S; Scheidereit C
Blood; 2019 Mar; 133(13):1489-1494. PubMed ID: 30696620
[TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of Hodgkin's lymphoma.
Küppers R; Schmitz R; Distler V; Renné C; Bräuninger A; Hansmann ML
Eur J Haematol Suppl; 2005 Jul; (66):26-33. PubMed ID: 16007865
[TBL] [Abstract][Full Text] [Related]
51. [Receptor tyrosine kinases in Hodgkin lymphoma as possible therapeutic targets].
Renné C; Hansmann ML; Bräuninger A
Pathologe; 2009 Sep; 30(5):393-400. PubMed ID: 19506874
[TBL] [Abstract][Full Text] [Related]
52. Non-Coding RNAs in Hodgkin Lymphoma.
Cordeiro A; Monzó M; Navarro A
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555062
[TBL] [Abstract][Full Text] [Related]
53. Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.
Nagel S; Ehrentraut S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
PLoS One; 2015; 10(9):e0138416. PubMed ID: 26406991
[TBL] [Abstract][Full Text] [Related]
54. Nodular lymphocyte predominant Hodgkin lymphoma.
Lee AI; LaCasce AS
Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
[TBL] [Abstract][Full Text] [Related]
55. [Molecular basis of Hodgkin lymphoma and anaplastic large cell lymphoma and molecular targeting therapy by an NF-kappaB inhibitor].
Horie R
Rinsho Ketsueki; 2007 Apr; 48(4):255-61. PubMed ID: 17515115
[No Abstract] [Full Text] [Related]
56. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
[TBL] [Abstract][Full Text] [Related]
57. Hodgkin lymphoma.
Schnitzer B
Hematol Oncol Clin North Am; 2009 Aug; 23(4):747-68. PubMed ID: 19577168
[TBL] [Abstract][Full Text] [Related]
58. A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples.
Sánchez-Espiridión B; Sánchez-Aguilera A; Montalbán C; Martin C; Martinez R; González-Carrero J; Poderos C; Bellas C; Fresno MF; Morante C; Mestre MJ; Mendez M; Mazorra F; Conde E; Castaño A; Sánchez-Godoy P; Tomas JF; Morente MM; Piris MA; García JF;
Clin Cancer Res; 2009 Feb; 15(4):1367-75. PubMed ID: 19228737
[TBL] [Abstract][Full Text] [Related]
59. Emerging therapies for B-cell non-Hodgkin lymphoma.
Briones J
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
[TBL] [Abstract][Full Text] [Related]
60. New molecular targets in Hodgkin and Reed-Sternberg cells.
Sadaf H; Ambroziak M; Binkowski R; Kluebsoongnoen J; Paszkiewicz-Kozik E; Steciuk J; Markowicz S; Walewski J; Sarnowska E; Sarnowski TJ; Konopinski R
Front Immunol; 2023; 14():1155468. PubMed ID: 37266436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
